24 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were to continue to be employed in the same position
8-K
EX-10.1
aiafu5 p74u1mj
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
pguvr7 12
16 Jun 22
Departure of Directors or Certain Officers
7:45am
10-K
m7kede tyf3
1 Mar 22
Annual report
4:07pm
10-K
EX-10.20
jkegjnd4yz
1 Mar 22
Annual report
4:07pm
10-Q
931j9a
2 Dec 21
Quarterly report
4:15pm
424B4
ehy4ohc
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
bywe6dzinq6nqcxd3
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.17
7w1ned864575
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.16
j50ylatc
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.15
8jps7md
1 Oct 21
IPO registration
4:49pm